Modulation of Social Cognition via Hallucinogens and “Entactogens”
Katrin H. Preller, Franz X. Vollenweider
Frontiers in Psychiatry December 3, 2019 DOI: 10.3389/fpsyt.2019.00881 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Hallucinogen Social cognition Cognitive psychology |
| Citations | 67 |
| Key findings | Hallucinogens and entactogens have the potential to modulate social processing, with implications for treating social cognition deficits in psychiatric disorders. |
Abstract
Social cognition is a fundamental ability in human everyday lives. Deficits in social functioning also represent a core aspect of many psychiatric disorders. Yet, despite its significance, deficits in social cognition skills are insufficiently targeted by current treatments. Hallucinogens and entactogens have been shown to have the potential to modulate social processing. This article reviews the literature on the influence of hallucinogens and entactogens on social processing in controlled experimental studies in humans and elucidates the underlying neurobiological and neuropharmacological mechanisms. Furthermore, it identifies current knowledge gaps and derives implications for hallucinogen-assisted treatment approaches as well as the development of novel medication for trans-diagnostic impairments in social cognition.
Citations in the library
Cited by 63
- Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study EClinicalMedicine September 24, 2020
- Classic Psychedelic Drugs: Update on Biological Mechanisms Pharmacopsychiatry January 25, 2022
- Belief changes associated with psychedelic use. Journal of Psychopharmacology 2023
- Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study Brain, Behavior, and Immunity September 7, 2023
- Psychedelics, Sociality, and Human Evolution Frontiers in Psychology September 29, 2021
and 58 more in the library
Cites 67
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
and 62 more in the library